CELESTICA INC (CLS.CA) Fundamental Analysis & Valuation

TSX:CLS • CA15101Q2071

361.36 CAD
-2.15 (-0.59%)
Last: Mar 11, 2026, 07:00 PM

This CLS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

CLS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 14 industry peers in the Electronic Equipment, Instruments & Components industry. Both the health and profitability get an excellent rating, making CLS a very profitable company, without any liquidiy or solvency issues. CLS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make CLS suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. CLS.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • Each year in the past 5 years CLS has been profitable.
  • CLS had a positive operating cash flow in each of the past 5 years.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS has a better Return On Assets (11.54%) than 100.00% of its industry peers.
  • CLS's Return On Equity of 37.56% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 24.36%, CLS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLS is significantly above the industry average of 10.17%.
  • The last Return On Invested Capital (24.36%) for CLS is above the 3 year average (17.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.72%, CLS is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • CLS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.80%, CLS is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • With a Gross Margin value of 12.06%, CLS is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

8

2. CLS.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • Compared to 1 year ago, CLS has less shares outstanding
  • CLS has less shares outstanding than it did 5 years ago.
  • CLS has a better debt/assets ratio than last year.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.25 indicates that CLS is not in any danger for bankruptcy at the moment.
  • CLS has a Altman-Z score (6.25) which is in line with its industry peers.
  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • CLS's Debt to FCF ratio of 1.69 is amongst the best of the industry. CLS outperforms 92.86% of its industry peers.
  • CLS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, CLS is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 6.25
ROIC/WACC2.94
WACC8.29%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • CLS has a Current ratio of 1.44. This is comparable to the rest of the industry: CLS outperforms 42.86% of its industry peers.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • The Quick ratio of CLS (0.88) is comparable to the rest of the industry.
  • CLS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. CLS.CA Growth Analysis

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.67% on average per year.
  • CLS shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.46%.
  • CLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.61% yearly.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 40.90% on average per year.
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.42% yearly.
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

6

4. CLS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 44.01, CLS can be considered very expensive at the moment.
  • CLS's Price/Earnings ratio is rather cheap when compared to the industry. CLS is cheaper than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, CLS is valued quite expensively.
  • CLS is valuated quite expensively with a Price/Forward Earnings ratio of 29.62.
  • 92.86% of the companies in the same industry are more expensive than CLS, based on the Price/Forward Earnings ratio.
  • CLS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.01
Fwd PE 29.62
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLS is cheaper than 85.71% of the companies in the same industry.
  • CLS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CLS is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 66.89
EV/EBITDA 27.32
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • CLS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of CLS may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 40.90% in the coming years.
PEG (NY)0.91
PEG (5Y)1.01
EPS Next 2Y46.28%
EPS Next 3Y40.9%

0

5. CLS.CA Dividend Analysis

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

CLS.CA Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

TSX:CLS (3/11/2026, 7:00:00 PM)

361.36

-2.15 (-0.59%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners72.98%
Inst Owner ChangeN/A
Ins Owners0.79%
Ins Owner ChangeN/A
Market Cap41.55B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.18
Price Target370.26 (2.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)0%
PT rev (3m)6.5%
EPS NQ rev (1m)2.86%
EPS NQ rev (3m)13.82%
EPS NY rev (1m)7.19%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)10.31%
Revenue NY rev (1m)7.29%
Revenue NY rev (3m)7.33%
Valuation
Industry RankSector Rank
PE 44.01
Fwd PE 29.62
P/S 2.47
P/FCF 66.89
P/OCF 46.48
P/B 13.83
P/tB 18.96
EV/EBITDA 27.32
EPS(TTM)8.21
EY2.27%
EPS(NY)12.2
Fwd EY3.38%
FCF(TTM)5.4
FCFY1.5%
OCF(TTM)7.77
OCFY2.15%
SpS146.07
BVpS26.13
TBVpS19.06
PEG (NY)0.91
PEG (5Y)1.01
Graham Number69.47
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 6.25
F-Score7
WACC8.29%
ROIC/WACC2.94
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS.CA FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS.CA) has a profitability rating of 8 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS.CA) is 44.01 and the Price/Book (PB) ratio is 13.83.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS.CA) is 8 / 10.